Personal information

No personal information available

Activities

Employment (2)

GlaxoSmithKline Biologicals: Siena, IT

Team Lead Pharmacovigilance
Employment
Source: Self-asserted source
Iris De Ryck

Institute of Tropical Medicine: Antwerp, BE

2011 | PhD research fellow HIV
Employment
Source: Self-asserted source
Iris De Ryck

Education and qualifications (4)

Université de Bordeaux: Bordeaux, FR

2015 | MsC Pharmacoepidemiology and Pharmacovigilance
Education
Source: Self-asserted source
Iris De Ryck

University of London: London, London, GB

2006 | Clinical Trial conduct PG
Education
Source: Self-asserted source
Iris De Ryck

Institute of Tropical Medicine: Antwerp, BE

2005 | Tropical Medicine and Public Health PG
Education
Source: Self-asserted source
Iris De Ryck

Katholieke Universiteit Leuven: Leuven, BE

2004 | Medical Doctor
Education
Source: Self-asserted source
Iris De Ryck

Works (20)

Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes

Drugs in R&D
2024-03 | Journal article
Contributors: Usman Nakakana; Alimamy Serry-Bangura; Bassey Effiom Edem; Pietro Tessitore; Leonardo Di Cesare; Danilo Gomes Moriel; Audino Podda; Iris Sarah De Ryck; Ashwani Kumar Arora
Source: check_circle
Crossref

Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

Drugs in R&D
2022-09 | Journal article
Contributors: Venanzio Vella; Johannes E. Schmidt; Giulia Luna Cilio; Iris De Ryck; Audino Podda; Valentino Conti; Joachim Auerbach
Source: check_circle
Crossref

Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

Infectious Diseases and Therapy
2022-06 | Journal article
Contributors: Iris De Ryck; Eleanna Sarakinou; Usman Nakakana; Giulia Luna Cilio; Augustin Ndiaye; Venanzio Vella; Joachim Auerbach; Juan-Paolo Granada; Valentino Conti; Audino Podda
Source: check_circle
Crossref

GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia

Infectious Diseases and Therapy
2022-04 | Journal article
Contributors: Iris De Ryck; Eleanna Sarakinou; Usman Nakakana; Giulia Luna Cilio; Augustin Ndiaye; Venanzio Vella; Joachim Auerbach; Juan-Paolo Granada; Valentino Conti; Audino Podda
Source: check_circle
Crossref

The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia

Drugs in R&D
2021-12-18 | Journal article
Part of ISSN: 1174-5886
Part of ISSN: 1179-6901
Source: Self-asserted source
Iris De Ryck
grade
Preferred source (of 2)‎

Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults

EClinicalMedicine
2021-09 | Journal article
Part of ISSN: 2589-5370
Source: Self-asserted source
Iris De Ryck

Returning to Elective Orthopedic Surgery During the COVID-19 Pandemic: A Multidisciplinary and Pragmatic Strategy for Initial Patient Selection.

Journal of patient safety
2020-12-01 | Journal article
Source: Self-asserted source
Iris De Ryck

Safety, Reactogenicity, and Immunogenicity of a Chimpanzee Adenovirus Vectored Ebola Vaccine in Children in Africa: A Randomised, Observer-Blind, Placebo-Controlled, Phase 2 Trial

Lancet Infect Dis.
2020-03-19 | Journal article
Source: Self-asserted source
Iris De Ryck

Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial.

Vaccine
2019-09-24 | Journal article
Source: Self-asserted source
Iris De Ryck

Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.

Vaccine
2019-05-21 | Journal article
Source: Self-asserted source
Iris De Ryck

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

The New England journal of medicine
2016-04 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study.

The Lancet. Infectious diseases
2016-03 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.

The Lancet. Infectious diseases
2016-01 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Chimpanzee Adenovirus Vector Ebola Vaccine--Preliminary Report.

The New England journal of medicine
2015-08 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Impact of Vaccine Effectiveness on Signal Detection Based on Disproportionality

2014-10 | Conference abstract
Source: Self-asserted source
Iris De Ryck

The use of erection enhancing medication and party drugs among men living with HIV in Europe.

AIDS care
2013-08 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Erectile dysfunction, testosterone deficiency, and risk of coronary heart disease in a cohort of men living with HIV in Belgium.

The journal of sexual medicine
2013-07 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

Awareness of hepatitis C infection among men who have sex with men in Flanders, Belgium.

Acta clinica Belgica
2011 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central

De Ryck, Iris, et al. "Gastrointestinal conditions in people living with HIV"

From the ground up: building comprehensive HIV/AIDS care programs in resource-limited settings. Volume 2: Establishing a framework for success
2009 | Book chapter
Source: Self-asserted source
Iris De Ryck

Universal access to HIV care: pitfalls and the way forward.

Tropical medicine & international health : TM & IH
2008-10 | Journal article
Source: Self-asserted source
Iris De Ryck via Europe PubMed Central